T1	chemical 33 39	oxygen
T2	disease_or_phenotypic_feature 78 85	obesity
T3	disease_or_phenotypic_feature 87 108	Peripheral neuropathy
T4	chemical 142 152	paclitaxel
T5	chemical 173 177	drug
T6	chemical 255 266	antagonists
T7	disease_or_phenotypic_feature 276 292	muscular atrophy
T8	chemical 375 383	antigens
T9	disease_or_phenotypic_feature 418 434	medulloblastomas
T10	chemical 449 455	enzyme
T11	chemical 471 479	nitrogen
T12	disease_or_phenotypic_feature 549 569	primary liver cancer
T13	disease_or_phenotypic_feature 642 655	heart failure
T14	disease_or_phenotypic_feature 670 683	heart failure
T15	chemical 704 710	sodium
T16	chemical 711 718	glucose
T17	chemical 795 803	antigens
T18	disease_or_phenotypic_feature 807 813	cancer
T19	chemical 814 824	biomarkers
T20	chemical 923 930	enzymes
T21	disease_or_phenotypic_feature 932 950	hyperbilirubinemia
T22	disease_or_phenotypic_feature 952 964	hypoglycemia
T23	disease_or_phenotypic_feature 966 983	hyperphosphatemia
T24	disease_or_phenotypic_feature 1015 1031	thrombocytopenia
T25	chemical 1033 1043	Decitabine
T26	disease_or_phenotypic_feature 1118 1124	cancer
T27	chemical 1132 1140	antigens
T28	chemical 1170 1195	Propranolol hydrochloride
T29	disease_or_phenotypic_feature 1229 1245	pheochromocytoma
T30	disease_or_phenotypic_feature 1270 1289	cardiac arrhythmias
T31	disease_or_phenotypic_feature 1312 1339	hypertrophic cardiomyopathy
T32	chemical 1355 1359	drug
T33	disease_or_phenotypic_feature 1375 1388	renal failure
T34	disease_or_phenotypic_feature 1408 1414	cancer
T35	chemical 1555 1567	biologically
T36	disease_or_phenotypic_feature 1629 1635	cancer
T37	disease_or_phenotypic_feature 1678 1704	adenocarcinoma of the lung
T38	chemical 1739 1742	his
T39	chemical 1766 1770	drug
T40	disease_or_phenotypic_feature 1783 1790	obesity
T41	disease_or_phenotypic_feature 1807 1814	obesity
T42	chemical 1863 1873	inhibitors
T43	chemical 1879 1890	biochemical
T44	disease_or_phenotypic_feature 1891 1903	hypoglycemia
T45	disease_or_phenotypic_feature 1916 1928	hypoglycemia
T46	chemical 1962 1970	estrogen
T47	disease_or_phenotypic_feature 2031 2047	pituitary tumors
T48	chemical 2102 2105	MCH
T49	chemical 2106 2117	antagonists
T50	disease_or_phenotypic_feature 2160 2167	obesity
T51	disease_or_phenotypic_feature 2206 2213	obesity
T52	chemical 2282 2299	nitrogen monoxide
T53	chemical 2300 2306	oxygen
T54	chemical 2307 2317	anesthesia
T55	chemical 2319 2330	Biochemical
T56	chemical 2387 2396	galactose
T57	disease_or_phenotypic_feature 2397 2406	cataracts
T58	chemical 2416 2424	nitrogen
T59	disease_or_phenotypic_feature 2478 2500	coronary heart disease
T60	disease_or_phenotypic_feature 2516 2526	arrhythmia
R1	causes_or_contributes_to Arg1:T4 Arg2:T3	
T61	missed_disease_or_phenotypic_feature 199 212	solid tumours
R2	treats Arg1:T4 Arg2:T61	
T62	corrected_chemical 241 245;255 266	ActA antagonists
T64	corrected_chemical 250 266	Mstn antagonists
R3	treats Arg1:T64 Arg2:T7	
R4	treats Arg1:T62 Arg2:T7	
T63	missed_disease_or_phenotypic_feature 297 306	mortality
R5	treats Arg1:T62 Arg2:T63	
R6	treats Arg1:T64 Arg2:T63	
T65	missed_disease_or_phenotypic_feature 1156 1168	solid tumors
R7	treats Arg1:T25 Arg2:T65	
R10	treats Arg1:T28 Arg2:T29	
T68	missed_disease_or_phenotypic_feature 1291 1306	angina pectoris
T69	missed_disease_or_phenotypic_feature 1247 1268	myocardial infarction
R11	treats Arg1:T28 Arg2:T69	
R12	treats Arg1:T28 Arg2:T30	
R13	treats Arg1:T28 Arg2:T31	
R14	treats Arg1:T28 Arg2:T68	
R15	treats Arg1:T39 Arg2:T37	
R16	causes_or_contributes_to Arg1:T46 Arg2:T47	
T70	corrected_chemical 2102 2117	MCH antagonists
R17	treats Arg1:T70 Arg2:T50	
R18	causes_or_contributes_to Arg1:T56 Arg2:T57	
R19	treats Arg1:T58 Arg2:T59	
R20	treats Arg1:T58 Arg2:T60	
R21	treats Arg1:T5 Arg2:T61	
R22	causes_or_contributes_to Arg1:T5 Arg2:T3	
T66	corrected_chemical 704 736	sodium-glucose co-transporters 2
R8	treats Arg1:T66 Arg2:T13	
T67	missed_disease_or_phenotypic_feature 662 683	risk of heart failure
R9	treats Arg1:T66 Arg2:T67	
T71	missed_disease_or_phenotypic_feature 1215 1227	hypertension
R23	treats Arg1:T28 Arg2:T71	
